{"transactions":[{"id":795255,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-01T20:15:07.000Z","date":"2026-04-23","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 23, 2026 and is scheduled to vest in equal monthly installments until April 23, 2029, subject to continued service."}],"balance_after":64000,"derivative":{"exercise_price":8.08,"expiration_date":"2036-04-22","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001193125-26-201468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526201468/ownership.xml","form_type":"4"}},{"id":1996157,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-23T22:02:15.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":600000,"derivative":{"exercise_price":2.18,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001209191-23-012259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919123012259/doc4.xml","form_type":"4"}},{"id":2385695,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-19T00:02:42.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of January 1, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":650000,"derivative":{"exercise_price":11.02,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001209191-22-011470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919122011470/doc4.xml","form_type":"4"}},{"id":2647980,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Series B Preferred Stock","published_at":"2021-07-01T23:00:35.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":19763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8126},"source":{"system":"sec-edgar","filing":"0000899243-21-027011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027011/doc4.xml","form_type":"4"}},{"id":2647979,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T23:00:35.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":340798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was granted subject to the achievement by the Company of performance vesting criteria. On June 29, 2021 the performance vesting criteria was met such that the option became reportable. 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."}],"balance_after":340798,"derivative":{"exercise_price":6.11,"expiration_date":"2031-03-16","underlying":"Common Stock","underlying_shares":340798},"source":{"system":"sec-edgar","filing":"0000899243-21-027011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027011/doc4.xml","form_type":"4"}},{"id":2647978,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T23:00:35.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":795196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering (\"IPO\") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."}],"balance_after":795196,"derivative":{"exercise_price":6.11,"expiration_date":"2031-03-16","underlying":"Common Stock","underlying_shares":795196},"source":{"system":"sec-edgar","filing":"0000899243-21-027011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027011/doc4.xml","form_type":"4"}},{"id":2647977,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Series B Preferred Stock","published_at":"2021-07-01T23:00:35.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":19763,"price":5.06,"value":100000.78,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering (\"IPO\") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."}],"balance_after":19763,"derivative":{"underlying":"Common Stock","underlying_shares":8126},"source":{"system":"sec-edgar","filing":"0000899243-21-027011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027011/doc4.xml","form_type":"4"}},{"id":2647976,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T23:00:35.000Z","date":"2021-01-16","kind":"exercise","acquired":false,"shares":374013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering (\"IPO\") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after April 20, 2020,  and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."}],"balance_after":0,"derivative":{"exercise_price":0.3,"expiration_date":"2031-01-12","underlying":"Common Stock","underlying_shares":374013},"source":{"system":"sec-edgar","filing":"0000899243-21-027011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027011/doc4.xml","form_type":"4"}},{"id":2647975,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T23:00:35.000Z","date":"2021-01-13","kind":"grant","acquired":true,"shares":374013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering (\"IPO\") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after April 20, 2020,  and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."}],"balance_after":374013,"derivative":{"exercise_price":0.3,"expiration_date":"2031-01-12","underlying":"Common Stock","underlying_shares":374013},"source":{"system":"sec-edgar","filing":"0000899243-21-027011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027011/doc4.xml","form_type":"4"}},{"id":2647974,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-07-01T23:00:35.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":8126,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date."}],"balance_after":1161670,"source":{"system":"sec-edgar","filing":"0000899243-21-027011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027011/doc4.xml","form_type":"4"}},{"id":2647973,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-07-01T23:00:35.000Z","date":"2021-01-16","kind":"exercise","acquired":true,"shares":374013,"price":0.3,"value":112203.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering (\"IPO\") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to this Reverse Stock Split."}],"balance_after":1153544,"source":{"system":"sec-edgar","filing":"0000899243-21-027011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000089924321027011/doc4.xml","form_type":"4"}},{"id":3219757,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-09T19:37:35.000Z","date":"2020-03-09","kind":"exercise","acquired":false,"shares":938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from September 8, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":1875,"derivative":{"exercise_price":19.89,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":938},"source":{"system":"sec-edgar","filing":"0000899243-20-007676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007676/doc4.xml","form_type":"4"}},{"id":3219756,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-09T19:37:35.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":938,"price":59.9,"value":56186.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $59.80 to $60.00 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2595,"source":{"system":"sec-edgar","filing":"0000899243-20-007676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007676/doc4.xml","form_type":"4"}},{"id":3219755,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-09T19:37:35.000Z","date":"2020-03-09","kind":"exercise","acquired":true,"shares":938,"price":19.89,"value":18656.82,"ownership":{"direct":true},"balance_after":3533,"source":{"system":"sec-edgar","filing":"0000899243-20-007676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007676/doc4.xml","form_type":"4"}},{"id":3219754,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-09T19:37:35.000Z","date":"2020-03-05","kind":"sale","acquired":false,"shares":1138,"price":65.3,"value":74311.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":2595,"source":{"system":"sec-edgar","filing":"0000899243-20-007676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007676/doc4.xml","form_type":"4"}},{"id":3226311,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-04T20:47:20.000Z","date":"2020-03-01","kind":"exercise","acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the RSUs shall vest in 8 equal semi-annual installments over 4 years from March 1, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of Common Stock underlying the RSUs shall vest in 8 equal semi-annual installments over 4 years from March 1, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":3500,"derivative":{"underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0000899243-20-007085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007085/doc4.xml","form_type":"4"}},{"id":3226310,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-04T20:47:20.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":612,"price":63.96,"value":39143.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,750 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":3733,"source":{"system":"sec-edgar","filing":"0000899243-20-007085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007085/doc4.xml","form_type":"4"}},{"id":3226309,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-04T20:47:20.000Z","date":"2020-03-01","kind":"exercise","acquired":true,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":4345,"source":{"system":"sec-edgar","filing":"0000899243-20-007085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007085/doc4.xml","form_type":"4"}},{"id":3258736,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-20T18:25:15.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":1313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from February 17, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":5250,"derivative":{"exercise_price":26.9,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":1313},"source":{"system":"sec-edgar","filing":"0000899243-20-005350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320005350/doc4.xml","form_type":"4"}},{"id":3258735,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-20T18:25:15.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":1313,"price":69.71,"value":91529.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":2595,"source":{"system":"sec-edgar","filing":"0000899243-20-005350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320005350/doc4.xml","form_type":"4"}},{"id":3258734,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-20T18:25:15.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":1313,"price":26.9,"value":35319.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":3908,"source":{"system":"sec-edgar","filing":"0000899243-20-005350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320005350/doc4.xml","form_type":"4"}},{"id":3281547,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T19:49:17.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from February 9, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":12.95,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0000899243-20-003859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003859/doc4.xml","form_type":"4"}},{"id":3281546,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-10T19:49:17.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":625,"price":70.48,"value":44050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":2595,"source":{"system":"sec-edgar","filing":"0000899243-20-003859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003859/doc4.xml","form_type":"4"}},{"id":3281545,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-10T19:49:17.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":625,"price":12.95,"value":8093.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":3220,"source":{"system":"sec-edgar","filing":"0000899243-20-003859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003859/doc4.xml","form_type":"4"}},{"id":3281544,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-10T19:49:17.000Z","date":"2020-02-06","kind":"sale","acquired":false,"shares":3937,"price":72.4,"value":285038.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":2595,"source":{"system":"sec-edgar","filing":"0000899243-20-003859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003859/doc4.xml","form_type":"4"}},{"id":3290498,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":38500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The shares of Common Stock underlying the option vest in 16 equal quarterly installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":38500,"derivative":{"exercise_price":65.82,"expiration_date":"2030-02-02","underlying":"Common Stock","underlying_shares":38500},"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290497,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":24160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":24160,"derivative":{"underlying":"Common Stock","underlying_shares":24160},"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290496,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":2188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":26250,"derivative":{"exercise_price":48.44,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":2188},"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290495,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":1657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":13250,"derivative":{"exercise_price":59.6,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":1657},"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290494,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-01","kind":"exercise","acquired":false,"shares":2938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":17625,"derivative":{"underlying":"Common Stock","underlying_shares":2938},"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290493,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-01","kind":"exercise","acquired":false,"shares":2125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":8500,"derivative":{"underlying":"Common Stock","underlying_shares":2125},"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290492,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-01","kind":"exercise","acquired":false,"shares":1037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from August 1, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from August 1, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":3113,"derivative":{"underlying":"Common Stock","underlying_shares":1037},"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290491,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":1657,"price":65,"value":107705.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":6532,"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290490,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":1657,"price":59.6,"value":98757.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":8189,"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290489,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":2188,"price":62.81,"value":137428.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":6532,"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290488,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":2188,"price":48.44,"value":105986.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":8720,"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290487,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-01","kind":"tax_withholding","acquired":false,"shares":2163,"price":65.26,"value":141157.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 6,100 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":6532,"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290486,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T20:47:57.000Z","date":"2020-02-01","kind":"exercise","acquired":true,"shares":6100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":8695,"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3290485,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T20:47:57.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":579,"price":36.68,"value":21237.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2595,"source":{"system":"sec-edgar","filing":"0000899243-20-003032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/doc4.xml","form_type":"4"}},{"id":3298627,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-29T16:47:51.000Z","date":"2020-01-27","kind":"exercise","acquired":false,"shares":781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from July 26, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":4688,"derivative":{"exercise_price":27.9,"expiration_date":"2027-07-25","underlying":"Common Stock","underlying_shares":781},"source":{"system":"sec-edgar","filing":"0000899243-20-002292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320002292/doc4.xml","form_type":"4"}},{"id":3298626,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-29T16:47:51.000Z","date":"2020-01-27","kind":"sale","acquired":false,"shares":781,"price":71.15,"value":55568.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":2016,"source":{"system":"sec-edgar","filing":"0000899243-20-002292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320002292/doc4.xml","form_type":"4"}},{"id":3298625,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-29T16:47:51.000Z","date":"2020-01-27","kind":"exercise","acquired":true,"shares":781,"price":27.9,"value":21789.9,"ownership":{"direct":true},"balance_after":2797,"source":{"system":"sec-edgar","filing":"0000899243-20-002292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320002292/doc4.xml","form_type":"4"}},{"id":3338137,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-12-17T20:15:31.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On December 13, 2019, the final performance milestone was achieved, resulting in the vesting of the remaining 4,000 shares of Common Stock underlying the RSU grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On December 13, 2019, the final performance milestone was achieved, resulting in the vesting of the remaining 4,000 shares of Common Stock underlying the RSU grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-19-029487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319029487/doc4.xml","form_type":"4"}},{"id":3338136,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-17T20:15:31.000Z","date":"2019-12-13","kind":"tax_withholding","acquired":false,"shares":1984,"price":76.88,"value":152529.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 4,000 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":2016,"source":{"system":"sec-edgar","filing":"0000899243-19-029487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319029487/doc4.xml","form_type":"4"}},{"id":3338135,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-17T20:15:31.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0000899243-19-029487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319029487/doc4.xml","form_type":"4"}},{"id":3344809,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-11T17:27:57.000Z","date":"2019-12-09","kind":"exercise","acquired":false,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from September 8, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":2813,"derivative":{"exercise_price":19.89,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0000899243-19-028940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028940/doc4.xml","form_type":"4"}},{"id":3344808,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-11T17:27:57.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":937,"price":78.5,"value":73554.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028940/doc4.xml","form_type":"4"}},{"id":3344807,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-11T17:27:57.000Z","date":"2019-12-09","kind":"exercise","acquired":true,"shares":937,"price":19.89,"value":18636.93,"ownership":{"direct":true},"balance_after":937,"source":{"system":"sec-edgar","filing":"0000899243-19-028940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028940/doc4.xml","form_type":"4"}},{"id":3357056,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-26","kind":"exercise","acquired":false,"shares":11593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":14907,"derivative":{"exercise_price":59.6,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":11593},"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357055,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":false,"shares":656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from February 17, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":6563,"derivative":{"exercise_price":26.9,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":656},"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357054,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":false,"shares":4594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from February 17, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":7219,"derivative":{"exercise_price":26.9,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":4594},"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357053,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":false,"shares":298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from September 8, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":3750,"derivative":{"exercise_price":19.89,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":298},"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357052,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":false,"shares":447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Common Stock underlying this option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":20,"expiration_date":"2025-08-10","underlying":"Common Stock","underlying_shares":447},"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357051,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":false,"shares":3515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from July 26, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":5469,"derivative":{"exercise_price":27.9,"expiration_date":"2027-07-25","underlying":"Common Stock","underlying_shares":3515},"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357050,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":false,"shares":1108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from September 8, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":4048,"derivative":{"exercise_price":19.89,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":1108},"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357049,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":false,"shares":312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from February 9, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":625,"derivative":{"exercise_price":12.95,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357048,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-26","kind":"sale","acquired":false,"shares":11593,"price":67.19,"value":778933.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357047,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-26","kind":"exercise","acquired":true,"shares":11593,"price":59.6,"value":690942.8,"ownership":{"direct":true},"balance_after":11593,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357046,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":656,"price":60,"value":39360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357045,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":true,"shares":656,"price":26.9,"value":17646.4,"ownership":{"direct":true},"balance_after":656,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357044,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":4594,"price":60,"value":275640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357043,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":true,"shares":4594,"price":26.9,"value":123578.6,"ownership":{"direct":true},"balance_after":4594,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357042,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":298,"price":60,"value":17880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357041,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":true,"shares":298,"price":19.89,"value":5927.22,"ownership":{"direct":true},"balance_after":298,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357040,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":447,"price":60,"value":26820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357039,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":true,"shares":447,"price":20,"value":8940.0,"ownership":{"direct":true},"balance_after":447,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357038,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":3515,"price":60,"value":210900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357037,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":true,"shares":3515,"price":27.9,"value":98068.5,"ownership":{"direct":true},"balance_after":3515,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357036,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":1108,"price":60,"value":66480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357035,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":true,"shares":1108,"price":19.89,"value":22038.12,"ownership":{"direct":true},"balance_after":1108,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357034,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":312,"price":60,"value":18720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3357033,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T16:47:26.000Z","date":"2019-11-25","kind":"exercise","acquired":true,"shares":312,"price":12.95,"value":4040.4,"ownership":{"direct":true},"balance_after":312,"source":{"system":"sec-edgar","filing":"0000899243-19-028243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/doc4.xml","form_type":"4"}},{"id":3363853,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-20T18:11:40.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":6562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":28438,"derivative":{"exercise_price":48.44,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":6562},"source":{"system":"sec-edgar","filing":"0000899243-19-027721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/doc4.xml","form_type":"4"}},{"id":3363852,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-20T18:11:40.000Z","date":"2019-11-18","kind":"exercise","acquired":false,"shares":656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from February 17, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":11813,"derivative":{"exercise_price":26.9,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":656},"source":{"system":"sec-edgar","filing":"0000899243-19-027721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/doc4.xml","form_type":"4"}},{"id":3363851,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-20T18:11:40.000Z","date":"2019-11-19","kind":"sale","acquired":false,"shares":6562,"price":55,"value":360910.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-027721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/doc4.xml","form_type":"4"}},{"id":3363850,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-20T18:11:40.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":6562,"price":48.44,"value":317863.28,"ownership":{"direct":true},"balance_after":6562,"source":{"system":"sec-edgar","filing":"0000899243-19-027721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/doc4.xml","form_type":"4"}},{"id":3363849,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-20T18:11:40.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":656,"price":50.63,"value":33213.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-027721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/doc4.xml","form_type":"4"}},{"id":3363848,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-20T18:11:40.000Z","date":"2019-11-18","kind":"exercise","acquired":true,"shares":656,"price":26.9,"value":17646.4,"ownership":{"direct":true},"balance_after":656,"source":{"system":"sec-edgar","filing":"0000899243-19-027721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/doc4.xml","form_type":"4"}},{"id":3367754,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":4594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from February 17, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":12469,"derivative":{"exercise_price":26.9,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":4594},"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367753,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Common Stock underlying this option vest in 16 equal quarterly installments over 4 years from September 8, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":5156,"derivative":{"exercise_price":19.89,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":298},"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367752,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Common Stock underlying this option are fully vested."}],"balance_after":447,"derivative":{"exercise_price":20,"expiration_date":"2025-08-10","underlying":"Common Stock","underlying_shares":118},"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367751,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":3516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from July 26, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":8984,"derivative":{"exercise_price":27.9,"expiration_date":"2027-07-25","underlying":"Common Stock","underlying_shares":3516},"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367750,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":1109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Common Stock underlying this option vest in 16 equal quarterly installments over 4 years from September 8, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":5454,"derivative":{"exercise_price":19.89,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":1109},"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367749,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Common Stock underlying this option are fully vested."}],"balance_after":937,"derivative":{"exercise_price":12.95,"expiration_date":"2025-03-04","underlying":"Common Stock","underlying_shares":313},"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367748,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-14","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Common Stock underlying this option are fully vested."}],"balance_after":565,"derivative":{"exercise_price":20,"expiration_date":"2025-08-10","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367747,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":9948,"price":50.0047,"value":497446.7556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $50.00 to $50.02 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367746,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":4594,"price":26.9,"value":123578.6,"ownership":{"direct":true},"balance_after":9948,"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367745,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":298,"price":19.89,"value":5927.22,"ownership":{"direct":true},"balance_after":5354,"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367744,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":118,"price":20,"value":2360.0,"ownership":{"direct":true},"balance_after":5056,"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367743,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":3516,"price":27.9,"value":98096.4,"ownership":{"direct":true},"balance_after":4938,"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367742,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":1109,"price":19.89,"value":22058.01,"ownership":{"direct":true},"balance_after":1422,"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367741,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":313,"price":12.95,"value":4053.35,"ownership":{"direct":true},"balance_after":313,"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367740,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-14","kind":"sale","acquired":false,"shares":329,"price":50.0137,"value":16454.5073,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $50.00 to $50.045 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3367739,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T17:43:33.000Z","date":"2019-11-14","kind":"exercise","acquired":true,"shares":329,"price":20,"value":6580.0,"ownership":{"direct":true},"balance_after":329,"source":{"system":"sec-edgar","filing":"0000899243-19-027545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/doc4.xml","form_type":"4"}},{"id":3397895,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-10-03T19:19:35.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the RSUs shall vest in 8 equal semi-annual installments over 4 years from October 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of Common Stock underlying the RSUs shall vest in 8 equal semi-annual installments over 4 years from October 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000899243-19-024981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319024981/doc4.xml","form_type":"4"}},{"id":3397894,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":50223,"kind":"person","name":"Lehrer-Graiwer Joshua","position":1,"cik":"0001789673","reported_name":"Lehrer-Graiwer Joshua","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-03T19:19:35.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from October 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":5000,"derivative":{"exercise_price":46.99,"expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-19-024981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319024981/doc4.xml","form_type":"4"}}]}